Show simple item record

 
dc.contributorHospital General de Granollers
dc.contributor.authorAzuaga, Ana Belén
dc.contributor.authorCuervo, Andrea
dc.contributor.authorCelis, Raquel
dc.contributor.authorFrade-Sosa, Beatriz
dc.contributor.authorSarmiento-Monroy, Juan Camilo
dc.contributor.authorRuiz-Esquide, Virginia
dc.contributor.authorGómez-Puerta, Jose A
dc.contributor.authorSanmarti, Raimon
dc.contributor.authorRamírez, Julio
dc.date.accessioned2024-05-23T10:27:13Z
dc.date.available2024-05-23T10:27:13Z
dc.date.issued2024-01-10
dc.identifier.citationAzuaga AB, Cuervo A, Celis R, Frade-Sosa B, Sarmiento-Monroy JC, Ruiz-Esquide V, et al. Synovial tissue features associated with poor prognosis in inflammatory arthritis. Arthritis Res Ther. 2024 Jan 10;26(1):18.
dc.identifier.issn1478-6362
dc.identifier.urihttps://hdl.handle.net/11351/11494
dc.descriptionPsoriatic arthritis; Rheumatoid arthritis; Synovial tissue
dc.description.abstractBackground: Inflammatory arthritis encompasses a group of immune-mediated diseases characterized by chronic joint inflammation. Despite having pathogenic mechanisms in common, the prognosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and undifferentiated arthritis (UA) could be different regarding progression to chronic, to erosive, or to self-limited disease. Our aim was to evaluate the potential association of synovial tissue (ST) inflammatory cell infiltrate, the presence of ectopic lymphoid neogenesis (LN +) structures, and poor prognosis factors (PPF) in patients with RA, PsA, and UA. Methods: We conducted a retrospective study including patients with active arthritis (RA, PsA, UA) who had ST obtained by rheumatological arthroscopy or ultrasound-guided biopsy. Clinical, demographic, and immunohistochemical data of the synovium was evaluated. Patients with biological therapy at the time of synovial biopsy were excluded. PPF in patients with RA and UA were defined by the presence of anti-cyclic citrullinated peptide antibodies and/or rheumatoid factor, development of bone erosions, or requirement of biological therapy during the follow-up. PPF in patients with PsA were defined as the presence of high levels of acute-phase reactants (ESR/CRP), dactylitis or nail involvement at the time of biopsy, development of bone erosion, or requirement of biological therapy during the follow-up. Results: A total of 88 patients were included: 26 RA, 33 PsA, and 29 UA. All patients were followed up for 5 years after the biopsy. Fourteen (53.84%) RA patients had PPF, and 17 (65.38%) had LN + . LN + was associated with PPF (p 0.038) and biologic therapy initiation (p 0.018). A total of 14 (43.75%) PsA patients had PPF. CD15 infiltrate (410.68 [SD 477.63] cells/mm2) was associated with PPF (p 0.008) in PsA patients. Sixteen (55.17%) patients with UA had PPF, and 13 (44.82%) had LN + . In this group, synovial CD68 + macrophages cells density was negatively correlated with DAS28-CRP (r = - 0.346, p 0.042). Conclusions: The presence of LN + and higher CD15 + polymorphonuclear cells infiltrate was associated with PPF in RA and PsA, respectively. No associations were found for UA. These findings suggest a great heterogeneity of the ST features and its pathogenic implications in the subtypes of inflammatory arthritis.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesArthritis Research & Therapy;26(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectArtritis psoriàsica
dc.subjectArtritis reumatoide
dc.subjectReumatisme
dc.subject.meshArthritis, Psoriatic
dc.subject.meshArthritis, Rheumatoid
dc.subject.meshSynovial Membrane
dc.titleSynovial tissue features associated with poor prognosis in inflammatory arthritis
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13075-023-03255-9
dc.subject.decsartritis psoriásica
dc.subject.decsartritis reumatoide
dc.subject.decsmembrana sinovial
dc.relation.publishversionhttps://doi.org/10.1186/s13075-023-03255-9
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Azuaga AB, Celis R, Frade-Sosa B, Sarmiento-Monroy JC, Ruiz-Esquide V, Gómez-Puerta JA, Sanmartí R, Ramírez J] Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain. [Cuervo A] Rheumatology Department, Hospital General de Granollers, Granollers, Spain
dc.identifier.pmid38200561
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record